Ashutosh Sharma
Corporate Officer/Principal bij New Jersey Institute of Technology
Profiel
Ashutosh Sharma is Vice President of Product and Process Development for Vyteris Holdings, Inc. Previously, he was Program Manager of Becton Dickinson.
Dr. Sharma received an MD from Rensselaer Polytechnic Institute and a Bachelor's degree from the Indian Institute of Technology in Kanpur, India.
Actieve functies van Ashutosh Sharma
Bedrijven | Functie | Begin |
---|---|---|
New Jersey Institute of Technology | Corporate Officer/Principal | - |
Eerdere bekende functies van Ashutosh Sharma
Bedrijven | Functie | Einde |
---|---|---|
BECTON, DICKINSON AND COMPANY | Corporate Officer/Principal | - |
Vyteris, Inc.
Vyteris, Inc. Pharmaceuticals: MajorHealth Technology Vyteris, Inc. develops, manufactures and commercializes pharmaceutical products. It is engaged in the process of developing first active drug delivery patch to receive marketing clearance from the U.S. Food and Drug Administration. The drug delivery patch technology allows precise dosing, giving physicians and patients control in the rate, dosage and pattern of drug delivery that may result in considerable therapeutic, economical, and lifestyle advantages over existing methods of drug administration. The company was founded on July 19, 2000 and is headquartered in Fair Lawn, NJ. | Corporate Officer/Principal | - |
Opleiding van Ashutosh Sharma
Rensselaer Polytechnic Institute | Doctorate Degree |
Indian Institute of Technology Kharagpur | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
BECTON, DICKINSON AND COMPANY | Health Technology |
Bedrijven in privébezit | 1 |
---|---|
Vyteris, Inc.
Vyteris, Inc. Pharmaceuticals: MajorHealth Technology Vyteris, Inc. develops, manufactures and commercializes pharmaceutical products. It is engaged in the process of developing first active drug delivery patch to receive marketing clearance from the U.S. Food and Drug Administration. The drug delivery patch technology allows precise dosing, giving physicians and patients control in the rate, dosage and pattern of drug delivery that may result in considerable therapeutic, economical, and lifestyle advantages over existing methods of drug administration. The company was founded on July 19, 2000 and is headquartered in Fair Lawn, NJ. | Health Technology |